CHALMERS DEREK T 4
4 · Cara Therapeutics, Inc. · Filed Dec 29, 2020
Insider Transaction Report
Form 4
CHALMERS DEREK T
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2020-12-28$16.00/sh−5,000$80,000→ 942,671 total - Award
Common Stock
2020-12-23+18,750→ 947,671 total
Footnotes (2)
- [F1]Represents the number of shares that vested under a performance-based restricted stock unit award (the "RSU") based on the Issuer's satisfaction of certain performance criteria of the award. In light of the performance-based vesting conditions of the award, such shares were not reportable under Section 16 until vesting was determined, which occurred on December 23, 2020. The vested shares represents the third of four possible vesting events of the total number of shares subject to the award. The remaining shares subject to the award will vest only upon the satisfaction of additional performance vesting criteria. Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- [F2]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2020.